DAVID U'PRICHARD

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Cyclacel Pharmaceuticals, Inc.

Filing Date Source Excerpt
2011-04-27 Dr. David U'Prichard 62 Chairman of the Board of Directors; Common Stock Nominee for Class 2 Director ... The Compensation and Organization Development Committee currently has three members: Dr. Christopher Henney (Chairman), Dr. Nicholas Bacopoulos and Dr. David U'Prichard.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-04